Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States

2013 ◽  
Vol 68 (3) ◽  
pp. 412-419 ◽  
Author(s):  
Irene Cosmatos ◽  
Amy Matcho ◽  
Rachel Weinstein ◽  
Michael O. Montgomery ◽  
Paul Stang
2018 ◽  
Vol 8 (4) ◽  
pp. 557-569 ◽  
Author(s):  
Alexandra B. Kimball ◽  
Murali Sundaram ◽  
Genevieve Gauthier ◽  
Annie Guérin ◽  
Irina Pivneva ◽  
...  

2013 ◽  
Vol 69 (5) ◽  
pp. 819 ◽  
Author(s):  
Irene Cosmatos ◽  
Amy Matcho ◽  
Rachel Weinstein ◽  
Michael O. Montgomery ◽  
Paul Stang

Author(s):  
Raveena Khanna ◽  
Katherine A. Whang ◽  
Amy H. Huang ◽  
Kyle A. Williams ◽  
Rayva Khanna ◽  
...  

2005 ◽  
Vol 8 (6) ◽  
pp. A203-A204
Author(s):  
EO Wu ◽  
HG Birnbaum ◽  
J Aggarwal ◽  
M Moulis

2018 ◽  
Vol 4 (1) ◽  
pp. 77-78
Author(s):  
Timothy Beukelman ◽  
Fenglong Xie ◽  
Ivan Foeldvari

Juvenile localised scleroderma is believed an orphan autoimmune disease, which occurs 10 times more often than systemic sclerosis in childhood and is believed to have a prevalence of 1 per 100,000 children. To gain data regarding the prevalence of juvenile localised scleroderma, we assessed the administrative claims data in the United States using the International Classification of Diseases, Ninth Revision diagnosis codes. We found an estimated prevalence in each year ranging from 3.2 to 3.6 per 10,000 children. This estimate is significantly higher as found in previous studies.


Sign in / Sign up

Export Citation Format

Share Document